Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. IBM
10. META

Go back to Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer
(NASDAQ: TNGX) Delayed: 28.50 --0 (-0%)
Previous Close $28.50    52 Week High $ 
Open $28.50    52 Week Low $ 
Day High $28.50    P/E N/A 
Day Low $28.50    EPS $ 
Volume 77